Lung Cancer Clinical Trials in Houston, TX

Lung Cancer Clinical Trials in Houston, TX

View the best 10 lung cancer medical studies in Houston, Texas. Access promising new therapies by applying to a Houston-based Lung Cancer clinical trial.

Trials in Houston, Texas

Here are the top 10 medical studies for lung cancer in Houston, Texas

Image of Yuma Regional Medical Center in Yuma, United States.

Tepotinib +1 More

MET inhibitor

Recruiting1 awardPhase 2
This trial will study the effects of a new cancer drug combination on lung cancer.
Image of Georgetown University in Washington, United States.

Osimertinib

Tyrosine Kinase Inhibitor

Recruiting1 awardPhase 2
This trial is testing whether adding ramucirumab to osimertinib improves progression-free survival for EGFR-mutated lung cancer patients.
Image of Research Site in Bellflower, United States.

Osimertinib

Tyrosine Kinase Inhibitor

Recruiting2 awardsPhase 3
This trial is testing whether adding chemotherapy to osimertinib will help people with non-small cell lung cancer that has a specific DNA mutation and has gotten worse despite osimertinib.
Image of University of Alabama at Birmingham in Birmingham, United States.

Zimberelimab +2 More

Monoclonal Antibodies

Recruiting1 awardPhase 2
This trial will study the safety and effectiveness of two different immunotherapy treatments for people with non-small cell lung cancer.
Image of Alabama Oncology Bruno Cancer Center ( Site 0001) in Birmingham, United States.

Carboplatin +3 More

Chemotherapy

Recruiting1 awardPhase 3
This trial will compare two treatments for people with squamous non-small cell lung cancer. One treatment will be pembrolizumab plus maintenance olaparib, and the other will be pembrolizumab plus maintenance olaparib placebo. The study's two primary hypotheses are that pembrolizumab plus maintenance olaparib is superior to pembrolizumab plus maintenance olaparib placebo with respect to progression-free survival and overall survival.
Image of Innovative Clinical Research Institute (ICRI) in Whittier, United States.

Atezolizumab +1 More

Checkpoint Inhibitor

Recruiting1 awardPhase 2
This trial will test the effectiveness of a new cancer treatment in people with squamous or non-squamous non-small cell lung cancer who haven't received prior systemic therapy. Up to 83 people will be enrolled in the study.
Image of Case Western Reserve University in Cleveland, United States.

Cisplatin +2 More

Platinum-containing Compound

Recruiting1 awardPhase 2
This trial is testing whether adding TRC102 to the usual care treatment of pemetrexed, cisplatin, and radiation therapy followed by durvalumab works better than the usual care treatment alone in patients with stage III non-squamous non-small cell lung cancer.
Image of Providence - Saint Joseph Home Health in Anaheim, United States.

Phase 3 comparator arm +3 More

Chemotherapy

Recruiting1 awardPhase 2 & 3
This trial tests two drugs, MRTX849 and pembrolizumab, in patients with advanced lung cancer who have a specific genetic mutation. MRTX849 targets the mutation to stop cancer growth, while pembrolizumab boosts the immune system to fight the cancer. The study aims to see how well these treatments work alone and together.
Image of Fairbanks Memorial Hospital in Fairbanks, United States.

Carboplatin +2 More

Alkylating agents

Recruiting1 awardPhase 2
This trial is testing pembrolizumab with or without chemotherapy to treat patients with stage IV non-small cell lung cancer that has come back and spread to other places in the body.
Image of Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro in Jonesboro, United States.

Stereotactic Body Radiation Therapy

Radiation

Recruiting2 awardsPhase 3
This trial is testing whether adding atezolizumab to radiation therapy works better than just radiation therapy alone in treating patients with early non-small cell lung cancer.

Phase 3 Trials

Trials With No Placebo

View More Related Trials

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.